aluates Reports

$ 0.0

Automative

Global Radioembolization Cancer Treatment Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-13D11554

Global Radioembolization Cancer Treatment Market Research Report 2022

BUY CHAPTERS

Global Radioembolization Cancer Treatment Market Research Report 2025

Code: QYRE-Auto-13D11554

Report

March 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Terumo Corporation

Merit Medical Systems

Cook Medical

Boston Scientific Corporation

Medtronic Inc

Stryker Corporation

Depuy Synthes (J&J)

BTG International Limited

Radioembolization Cancer Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Radioembolization Cancer Treatment Market

The global market for Radioembolization Cancer Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Radioembolization Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioembolization Cancer Treatment.

The Radioembolization Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radioembolization Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Radioembolization Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Radioembolization Cancer Treatment Market Report

Report Metric	Details
Report Name	Radioembolization Cancer Treatment Market
CAGR	5%
Segment by Type	Transarterial Radioembolization (TARE) Selective Internal Radiation Therapy (SIRT)
Segment by Application	Hospital Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Terumo Corporation, Merit Medical Systems, Cook Medical, Boston Scientific Corporation, Medtronic, Stryker Corporation, Depuy Synthes (J&J), BTG International Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioembolization Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Radioembolization Cancer Treatment Market report?

Ans: The main players in the Radioembolization Cancer Treatment Market are Terumo Corporation, Merit Medical Systems, Cook Medical, Boston Scientific Corporation, Medtronic, Stryker Corporation, Depuy Synthes (J&J), BTG International Limited

What are the Application segmentation covered in the Radioembolization Cancer Treatment Market report?

Ans: The Applications covered in the Radioembolization Cancer Treatment Market report are Hospital, Clinics, Others

What are the Type segmentation covered in the Radioembolization Cancer Treatment Market report?

Ans: The Types covered in the Radioembolization Cancer Treatment Market report are Transarterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT)

Recommended Reports

Cancer Therapies

Radiation Therapy

Cancer Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Radioembolization Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Transarterial Radioembolization (TARE)

1.2.3 Selective Internal Radiation Therapy (SIRT)

1.3 Market by Application

1.3.1 Global Radioembolization Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Radioembolization Cancer Treatment Market Perspective (2020-2031)

2.2 Global Radioembolization Cancer Treatment Growth Trends by Region

2.2.1 Global Radioembolization Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Radioembolization Cancer Treatment Historic Market Size by Region (2020-2025)

2.2.3 Radioembolization Cancer Treatment Forecasted Market Size by Region (2026-2031)

2.3 Radioembolization Cancer Treatment Market Dynamics

2.3.1 Radioembolization Cancer Treatment Industry Trends

2.3.2 Radioembolization Cancer Treatment Market Drivers

2.3.3 Radioembolization Cancer Treatment Market Challenges

2.3.4 Radioembolization Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Radioembolization Cancer Treatment Players by Revenue

3.1.1 Global Top Radioembolization Cancer Treatment Players by Revenue (2020-2025)

3.1.2 Global Radioembolization Cancer Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Radioembolization Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Radioembolization Cancer Treatment Revenue

3.4 Global Radioembolization Cancer Treatment Market Concentration Ratio

3.4.1 Global Radioembolization Cancer Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Radioembolization Cancer Treatment Revenue in 2024

3.5 Global Key Players of Radioembolization Cancer Treatment Head office and Area Served

3.6 Global Key Players of Radioembolization Cancer Treatment, Product and Application

3.7 Global Key Players of Radioembolization Cancer Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Radioembolization Cancer Treatment Breakdown Data by Type

4.1 Global Radioembolization Cancer Treatment Historic Market Size by Type (2020-2025)

4.2 Global Radioembolization Cancer Treatment Forecasted Market Size by Type (2026-2031)

5 Radioembolization Cancer Treatment Breakdown Data by Application

5.1 Global Radioembolization Cancer Treatment Historic Market Size by Application (2020-2025)

5.2 Global Radioembolization Cancer Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Radioembolization Cancer Treatment Market Size (2020-2031)

6.2 North America Radioembolization Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Radioembolization Cancer Treatment Market Size by Country (2020-2025)

6.4 North America Radioembolization Cancer Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Radioembolization Cancer Treatment Market Size (2020-2031)

7.2 Europe Radioembolization Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Radioembolization Cancer Treatment Market Size by Country (2020-2025)

7.4 Europe Radioembolization Cancer Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Radioembolization Cancer Treatment Market Size (2020-2031)

8.2 Asia-Pacific Radioembolization Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Radioembolization Cancer Treatment Market Size (2020-2031)

9.2 Latin America Radioembolization Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Radioembolization Cancer Treatment Market Size by Country (2020-2025)

9.4 Latin America Radioembolization Cancer Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Radioembolization Cancer Treatment Market Size (2020-2031)

10.2 Middle East & Africa Radioembolization Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Terumo Corporation

11.1.1 Terumo Corporation Company Details

11.1.2 Terumo Corporation Business Overview

11.1.3 Terumo Corporation Radioembolization Cancer Treatment Introduction

11.1.4 Terumo Corporation Revenue in Radioembolization Cancer Treatment Business (2020-2025)

11.1.5 Terumo Corporation Recent Development

11.2 Merit Medical Systems

11.2.1 Merit Medical Systems Company Details

11.2.2 Merit Medical Systems Business Overview

11.2.3 Merit Medical Systems Radioembolization Cancer Treatment Introduction

11.2.4 Merit Medical Systems Revenue in Radioembolization Cancer Treatment Business (2020-2025)

11.2.5 Merit Medical Systems Recent Development

11.3 Cook Medical

11.3.1 Cook Medical Company Details

11.3.2 Cook Medical Business Overview

11.3.3 Cook Medical Radioembolization Cancer Treatment Introduction

11.3.4 Cook Medical Revenue in Radioembolization Cancer Treatment Business (2020-2025)

11.3.5 Cook Medical Recent Development

11.4 Boston Scientific Corporation

11.4.1 Boston Scientific Corporation Company Details

11.4.2 Boston Scientific Corporation Business Overview

11.4.3 Boston Scientific Corporation Radioembolization Cancer Treatment Introduction

11.4.4 Boston Scientific Corporation Revenue in Radioembolization Cancer Treatment Business (2020-2025)

11.4.5 Boston Scientific Corporation Recent Development

11.5 Medtronic

11.5.1 Medtronic Company Details

11.5.2 Medtronic Business Overview

11.5.3 Medtronic Radioembolization Cancer Treatment Introduction

11.5.4 Medtronic Revenue in Radioembolization Cancer Treatment Business (2020-2025)

11.5.5 Medtronic Recent Development

11.6 Stryker Corporation

11.6.1 Stryker Corporation Company Details

11.6.2 Stryker Corporation Business Overview

11.6.3 Stryker Corporation Radioembolization Cancer Treatment Introduction

11.6.4 Stryker Corporation Revenue in Radioembolization Cancer Treatment Business (2020-2025)

11.6.5 Stryker Corporation Recent Development

11.7 Depuy Synthes (J&J)

11.7.1 Depuy Synthes (J&J) Company Details

11.7.2 Depuy Synthes (J&J) Business Overview

11.7.3 Depuy Synthes (J&J) Radioembolization Cancer Treatment Introduction

11.7.4 Depuy Synthes (J&J) Revenue in Radioembolization Cancer Treatment Business (2020-2025)

11.7.5 Depuy Synthes (J&J) Recent Development

11.8 BTG International Limited

11.8.1 BTG International Limited Company Details

11.8.2 BTG International Limited Business Overview

11.8.3 BTG International Limited Radioembolization Cancer Treatment Introduction

11.8.4 BTG International Limited Revenue in Radioembolization Cancer Treatment Business (2020-2025)

11.8.5 BTG International Limited Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Terumo Corporation

Merit Medical Systems

Cook Medical

Boston Scientific Corporation

Medtronic Inc

Stryker Corporation

Depuy Synthes (J&J)

BTG International Limited

List of Tables

Table 1. Global Radioembolization Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Transarterial Radioembolization (TARE)

Table 3. Key Players of Selective Internal Radiation Therapy (SIRT)

Table 4. Global Radioembolization Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Radioembolization Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Radioembolization Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Radioembolization Cancer Treatment Market Share by Region (2020-2025)

Table 8. Global Radioembolization Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Radioembolization Cancer Treatment Market Share by Region (2026-2031)

Table 10. Radioembolization Cancer Treatment Market Trends

Table 11. Radioembolization Cancer Treatment Market Drivers

Table 12. Radioembolization Cancer Treatment Market Challenges

Table 13. Radioembolization Cancer Treatment Market Restraints

Table 14. Global Radioembolization Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Radioembolization Cancer Treatment Market Share by Players (2020-2025)

Table 16. Global Top Radioembolization Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioembolization Cancer Treatment as of 2024)

Table 17. Ranking of Global Top Radioembolization Cancer Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Radioembolization Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Radioembolization Cancer Treatment, Headquarters and Area Served

Table 20. Global Key Players of Radioembolization Cancer Treatment, Product and Application

Table 21. Global Key Players of Radioembolization Cancer Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Radioembolization Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Radioembolization Cancer Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Radioembolization Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Radioembolization Cancer Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Radioembolization Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Radioembolization Cancer Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Radioembolization Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Radioembolization Cancer Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Radioembolization Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Radioembolization Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Radioembolization Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Radioembolization Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Radioembolization Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Radioembolization Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Radioembolization Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Radioembolization Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Radioembolization Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Radioembolization Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Radioembolization Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Terumo Corporation Company Details

Table 47. Terumo Corporation Business Overview

Table 48. Terumo Corporation Radioembolization Cancer Treatment Product

Table 49. Terumo Corporation Revenue in Radioembolization Cancer Treatment Business (2020-2025) & (US$ Million)

Table 50. Terumo Corporation Recent Development

Table 51. Merit Medical Systems Company Details

Table 52. Merit Medical Systems Business Overview

Table 53. Merit Medical Systems Radioembolization Cancer Treatment Product

Table 54. Merit Medical Systems Revenue in Radioembolization Cancer Treatment Business (2020-2025) & (US$ Million)

Table 55. Merit Medical Systems Recent Development

Table 56. Cook Medical Company Details

Table 57. Cook Medical Business Overview

Table 58. Cook Medical Radioembolization Cancer Treatment Product

Table 59. Cook Medical Revenue in Radioembolization Cancer Treatment Business (2020-2025) & (US$ Million)

Table 60. Cook Medical Recent Development

Table 61. Boston Scientific Corporation Company Details

Table 62. Boston Scientific Corporation Business Overview

Table 63. Boston Scientific Corporation Radioembolization Cancer Treatment Product

Table 64. Boston Scientific Corporation Revenue in Radioembolization Cancer Treatment Business (2020-2025) & (US$ Million)

Table 65. Boston Scientific Corporation Recent Development

Table 66. Medtronic Company Details

Table 67. Medtronic Business Overview

Table 68. Medtronic Radioembolization Cancer Treatment Product

Table 69. Medtronic Revenue in Radioembolization Cancer Treatment Business (2020-2025) & (US$ Million)

Table 70. Medtronic Recent Development

Table 71. Stryker Corporation Company Details

Table 72. Stryker Corporation Business Overview

Table 73. Stryker Corporation Radioembolization Cancer Treatment Product

Table 74. Stryker Corporation Revenue in Radioembolization Cancer Treatment Business (2020-2025) & (US$ Million)

Table 75. Stryker Corporation Recent Development

Table 76. Depuy Synthes (J&J) Company Details

Table 77. Depuy Synthes (J&J) Business Overview

Table 78. Depuy Synthes (J&J) Radioembolization Cancer Treatment Product

Table 79. Depuy Synthes (J&J) Revenue in Radioembolization Cancer Treatment Business (2020-2025) & (US$ Million)

Table 80. Depuy Synthes (J&J) Recent Development

Table 81. BTG International Limited Company Details

Table 82. BTG International Limited Business Overview

Table 83. BTG International Limited Radioembolization Cancer Treatment Product

Table 84. BTG International Limited Revenue in Radioembolization Cancer Treatment Business (2020-2025) & (US$ Million)

Table 85. BTG International Limited Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Radioembolization Cancer Treatment Picture

Figure 2. Global Radioembolization Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Radioembolization Cancer Treatment Market Share by Type: 2024 VS 2031

Figure 4. Transarterial Radioembolization (TARE) Features

Figure 5. Selective Internal Radiation Therapy (SIRT) Features

Figure 6. Global Radioembolization Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Radioembolization Cancer Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Radioembolization Cancer Treatment Report Years Considered

Figure 12. Global Radioembolization Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Radioembolization Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Radioembolization Cancer Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Radioembolization Cancer Treatment Market Share by Players in 2024

Figure 16. Global Top Radioembolization Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioembolization Cancer Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Radioembolization Cancer Treatment Revenue in 2024

Figure 18. North America Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Radioembolization Cancer Treatment Market Share by Country (2020-2031)

Figure 20. United States Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Radioembolization Cancer Treatment Market Share by Country (2020-2031)

Figure 24. Germany Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Radioembolization Cancer Treatment Market Share by Region (2020-2031)

Figure 32. China Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Radioembolization Cancer Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Radioembolization Cancer Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Radioembolization Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Terumo Corporation Revenue Growth Rate in Radioembolization Cancer Treatment Business (2020-2025)

Figure 48. Merit Medical Systems Revenue Growth Rate in Radioembolization Cancer Treatment Business (2020-2025)

Figure 49. Cook Medical Revenue Growth Rate in Radioembolization Cancer Treatment Business (2020-2025)

Figure 50. Boston Scientific Corporation Revenue Growth Rate in Radioembolization Cancer Treatment Business (2020-2025)

Figure 51. Medtronic Revenue Growth Rate in Radioembolization Cancer Treatment Business (2020-2025)

Figure 52. Stryker Corporation Revenue Growth Rate in Radioembolization Cancer Treatment Business (2020-2025)

Figure 53. Depuy Synthes (J&J) Revenue Growth Rate in Radioembolization Cancer Treatment Business (2020-2025)

Figure 54. BTG International Limited Revenue Growth Rate in Radioembolization Cancer Treatment Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anti Radiation Drug Market Research Report 2024

Radiation Therapy Treatment Planning System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

X ray Intraoperative Radiation Therapy System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tumor Ablation Therapy Market Research Report 2024

Global Radiopharmaceutical Solutions Market Research Report 2025

Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiopharmaceutical Injectors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global External Beam Radiotherapy Market Research Report 2024

Radiological Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Radiotherapy Dosimetry Market Research Report 2024

Global Thrombolytic Treatment Market Research Report 2024

Global Liver Cancer Treatment Drug Market Research Report 2025

Radioembolization Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pulmonary Embolism Drug Market Research Report 2025

Radiopharmaceutical Oral Route Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiation Therapy Positioning Tables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Brain Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions